Vik Chopra
Stock Analyst at Wells Fargo
(3.39)
# 955
Out of 5,163 analysts
68
Total ratings
48.28%
Success rate
6.11%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Equal-Weight | $86 → $83 | $66.76 | +24.33% | 6 | Feb 27, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $13 → $12 | $9.24 | +29.87% | 3 | Feb 27, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $12 → $13 | $11.54 | +12.65% | 5 | Feb 27, 2026 | |
| GMED Globus Medical | Maintains: Overweight | $98 → $104 | $84.77 | +22.68% | 12 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $76 → $87 | $75.57 | +15.13% | 4 | Feb 25, 2026 | |
| MASI Masimo | Downgrades: Equal-Weight | $190 → $180 | $175.49 | +2.57% | 11 | Feb 18, 2026 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $21 → $26 | $24.61 | +5.65% | 4 | Feb 6, 2026 | |
| ALGN Align Technology | Maintains: Overweight | $181 → $200 | $164.23 | +21.78% | 5 | Feb 5, 2026 | |
| CNMD CONMED | Maintains: Equal-Weight | $41 → $42 | $37.28 | +12.66% | 7 | Jan 29, 2026 | |
| ENOV Enovis | Maintains: Overweight | $41 → $42 | $22.99 | +82.69% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $16 | $14.09 | +13.56% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $12.28 | +30.29% | 2 | Oct 16, 2025 |
Solventum
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $86 → $83
Current: $66.76
Upside: +24.33%
Integra LifeSciences Holdings
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $13 → $12
Current: $9.24
Upside: +29.87%
DENTSPLY SIRONA
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $11.54
Upside: +12.65%
Globus Medical
Feb 26, 2026
Maintains: Overweight
Price Target: $98 → $104
Current: $84.77
Upside: +22.68%
Henry Schein
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $76 → $87
Current: $75.57
Upside: +15.13%
Masimo
Feb 18, 2026
Downgrades: Equal-Weight
Price Target: $190 → $180
Current: $175.49
Upside: +2.57%
Envista Holdings
Feb 6, 2026
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $24.61
Upside: +5.65%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $181 → $200
Current: $164.23
Upside: +21.78%
CONMED
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $41 → $42
Current: $37.28
Upside: +12.66%
Enovis
Nov 7, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $22.99
Upside: +82.69%
Nov 5, 2025
Maintains: Overweight
Price Target: $15 → $16
Current: $14.09
Upside: +13.56%
Oct 16, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $12.28
Upside: +30.29%